Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18579811 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Enoxaparin

Indicates status has not been verified in more than two years